Slide 1: Strong result in a weak market environment
Strong result in a weak market environment Raisio's Half-Year Report H1/2023 CEO Pekka Kuusniemi Raisio plc, 9 August 2023
Slide 2: Raisio Group's net sales and EBIT H1/2023
Raisio Group's net sales and EBIT H1/2023 Continuing operations without Raisioaqua NET SALES COMPARABLE EBIT AND COMPARABLE PROFITABILITY IMPROVED BY 67.8% IN EBITDA JANUARY–JUNE M€ M€ +36.7% +0.4% • High inflation and rising interest rates have 120 14.9 14,9 affected consumer demand in many 15 108,
Slide 3: Raisio Group's net sales and EBIT Q2/2023
Raisio Group's net sales and EBIT Q2/2023 Continuing operations without Raisioaqua NET SALES COMPARABLE EBIT AND APRIL–JUNE'S NET SALES DECREASED COMPARABLE EBITDA BY -5.1% M€ M€ +18.8% -5.1% • In the consumer markets, net sales 8.2 8,2 varied between markets: the value of 60 55.5 55,5 8 +29.5% sale
Slide 4: Cash flow significantly boosted
Cash flow significantly boosted H1/23 H1/22 IMPROVED GROSS MARGIN BOOSTED CASH FLOW Cash flow, M€ 13,0 -1.4 • As planned, investments were Investments, M€ 4.9 2.6 moderate compared to previous years, at 4.5% (2.4%) of net sales. Equity ratio, % 78.9 78.3 • Working capital remained at a high Equity p
Slide 5: Raisio's outlook 2023
RAISIO’S NEW GUIDANCE 10 JULY 2023: Raisio expects comparable net sales to be at or slightly below the previous year’s level. Comparable profit is Raisio’s expected to increase from the outlook previous year, to between EUR 21 and 23 million. 2023 Raisio's previous guidance for 2023: The company is
Slide 6: Healthy Food
Healthy Food
Slide 7: Healthy Food Segment Q2/2023
Healthy Food Segment Q2/2023 • Healthy brand products for consumers • Main market areas Finland, the UK, Ireland, Ukraine, Poland GEOGRAPHICAL BREAKDOWN OF NET SALES QUARTERLY DEVELOPMENT OF NET SALES: Q2/2023: Q3/22 vs Q4/22 vs Q1/23 vs Q2/23 vs 6% Q3/21 Q4/21 Q1/22 Q2/22 44 % Western Europe Northe
Slide 8: Healthy Food Segment's net sales and EBIT Q2/2023
Healthy Food Segment’s net sales and EBIT Q2/2023 Continuing operations NET SALES COMPARABLE STRONG VARIATION BETWEEN BOTH EBIT MARKET AREAS AND PRODUCT M€ +4.9% CATEGORIES M€ -0.6% • The UK Benecol® business saw a decline in net 40 4,3 4.3 sales but maintained a high market share. 35,1 35.1 34.9 34
Slide 9: Healthy Ingredients
Healthy Ingredients
Slide 10: Healthy Ingredients Segment Q2/2023
Healthy Ingredients Segment Q2/2023 INGREDIENTS • Sale of grain-based foods and ingredients and sale of plant proteins to industrial and catering companies • Benecol® licensing • Global market with a focus on Europe 9 August 2022 Raisio’s Half-Year Report January–June 2023 10
Slide 11: Healthy Ingredients Segment's net sales and EBIT Q2/2023
Healthy Ingredients Segment’s net sales and EBIT Q2/2023 Continuing operations NET SALES COMPARABLE EBIT APRIL–JUNE'S NET SALES DECREASED BY -11.2% M€ -11.2% M€ +35.7% • The value of B2B sales of grain-based products increased slightly and 2 1,9 1.9 30 29,4 29.4 profitability improved significantly
Slide 12: Raisio's Healthy Growth Strategy 2022–2025: Tailwind behind our back
Raisio's Healthy Growth Tailwind behind our back Strategy 2022–2025 Plant-based eating High-quality options As plant-based eating becomes more Benecol® and widespread and the range of products on plant stanol ester offer expands, more and more expectations solutions are being placed on product quali
Slide 13: Development of strategic growth drivers H1/2023
Development of strategic growth drivers H1/2023 1–6/2022 1–6/2023 2022 OUTTURN H1/2023 During the review period, the Net sales M€ 108.7 109.1 220.8 combined net sales of the three strategic focus areas grew by Benecol® and plant stanol 1.9%. M€ 56.8 54.7 113.8 ester solutions • After the changes in
Slide 14: Food for Health, Heart and Earth.
Food for Health, Heart and Earth.
Slide 15: raisio.com
raisio.com